Cleveland Clinic and the analytics software vendor SAS have jointly developed predictive models to help hospitals prepare for three COVID-19 scenarios—worst case, best case and most likely.
Glioma patients typically need a biopsy so physicians can make a treatment decision, but researchers have developed a new AI algorithm that could make such biopsies unnecessary.
With so many eyes fixed on New York City as the “epicenter” of the COVID-19 crisis in the U.S., it might go unnoticed at the national level that nearly 60,000 infections could be recorded some 150 miles to the north by June 8.
Researchers in Israel are working to develop a new AI-powered COVID-19 test—and they think it could be especially effective at detecting individuals who carry the virus without showing any symptoms.
The feat may offer a way for physicians to watch for signs of deterioration in patients who have too mild a case of the disease to warrant hospitalization but may need quick response if the condition worsens.
An AI-championing health-tech company whose name sounds like that of a consumer group has announced a formal partnership with the Big Tech corporation behind the AI-pioneering Watson technology.
Stopping scams before they’re perpetrated, cutting illicit payments and reducing hours spent by staff on such cases are three of the top benefits administrators believe artificial intelligence could deliver to their operations.
